NO20055694D0 - Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav - Google Patents
Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater deravInfo
- Publication number
- NO20055694D0 NO20055694D0 NO20055694A NO20055694A NO20055694D0 NO 20055694 D0 NO20055694 D0 NO 20055694D0 NO 20055694 A NO20055694 A NO 20055694A NO 20055694 A NO20055694 A NO 20055694A NO 20055694 D0 NO20055694 D0 NO 20055694D0
- Authority
- NO
- Norway
- Prior art keywords
- hydroxy
- preparation
- acetonitrile
- pyran
- tetrahydro
- Prior art date
Links
- NUTZEIABCUGDLR-UHFFFAOYSA-N 2-(4-hydroxy-6-oxooxan-2-yl)acetonitrile Chemical compound OC1CC(CC#N)OC(=O)C1 NUTZEIABCUGDLR-UHFFFAOYSA-N 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 abstract 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract 1
- 159000000007 calcium salts Chemical class 0.000 abstract 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Epoxy Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03101227 | 2003-05-02 | ||
| PCT/NL2004/000284 WO2004096788A1 (en) | 2003-05-02 | 2004-04-28 | Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20055694D0 true NO20055694D0 (no) | 2005-12-01 |
| NO20055694L NO20055694L (no) | 2006-02-02 |
Family
ID=33395971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055694A NO20055694L (no) | 2003-05-02 | 2005-12-01 | Fremgangsmate for fremstilling av (4-hydroksy-6-oksotetrahydropyran-2-yl)acetonitril og derivater derav |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7423162B2 (no) |
| EP (1) | EP1620423B1 (no) |
| JP (1) | JP2006525323A (no) |
| KR (1) | KR20060011984A (no) |
| CN (2) | CN101775000B (no) |
| AT (1) | ATE386734T1 (no) |
| AU (1) | AU2004234308A1 (no) |
| BR (1) | BRPI0409866A (no) |
| CA (1) | CA2524457A1 (no) |
| CO (1) | CO5700715A2 (no) |
| CY (1) | CY1113498T1 (no) |
| DE (1) | DE602004011921T2 (no) |
| DK (1) | DK1620423T3 (no) |
| EA (1) | EA010100B1 (no) |
| ES (1) | ES2300769T3 (no) |
| IL (1) | IL171539A (no) |
| IS (1) | IS8159A (no) |
| NO (1) | NO20055694L (no) |
| NZ (1) | NZ543294A (no) |
| PL (1) | PL1620423T3 (no) |
| SI (1) | SI1620423T1 (no) |
| UA (1) | UA83662C2 (no) |
| WO (1) | WO2004096788A1 (no) |
| ZA (1) | ZA200508862B (no) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101113163B1 (ko) | 2003-07-25 | 2012-02-17 | 브래드포드 파마 리미티드 | 스타틴, 특히 아토르바스타틴의 제조에 유용한 중간체화합물 및 그 제조방법 |
| US7701550B2 (en) | 2004-08-19 | 2010-04-20 | Asml Netherlands B.V. | Lithographic apparatus and device manufacturing method |
| DE102005022284A1 (de) | 2005-05-13 | 2006-11-23 | Ratiopharm Gmbh | Verfahren zur Herstellung von Statinen |
| US8047545B2 (en) * | 2007-11-07 | 2011-11-01 | Douglas Press, Inc. | Lottery-type game with rollover feature |
| WO2009092702A2 (en) * | 2008-01-23 | 2009-07-30 | Lek Pharmaceuticals D.D. | ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production thereof |
| SI2614057T1 (sl) * | 2010-09-09 | 2016-03-31 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Soli estrov 7-amino-3,5-dihidroksi heptanojske kisline |
| US20130178636A1 (en) * | 2010-09-16 | 2013-07-11 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Esters of hexanoic acids as intermediates for the preparation of atorvastatin |
| CN105669637A (zh) * | 2014-11-21 | 2016-06-15 | 南京博优康远生物医药科技有限公司 | 一种3,5,6-取代己酸酯衍生物的制备方法 |
| CN112501223B (zh) * | 2020-11-23 | 2022-08-12 | 江苏阿尔法药业股份有限公司 | 制备2-((2r，4r)-4-羟基-6-氧代四氢-2h-吡喃-2-基)乙腈的方法 |
| CN116102482A (zh) * | 2022-08-17 | 2023-05-12 | 重庆普佑生物医药有限公司 | 一种阿托伐他汀钙的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5003080A (en) * | 1988-02-22 | 1991-03-26 | Warner-Lambert Company | Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis |
| US5097045A (en) * | 1989-02-01 | 1992-03-17 | Warner-Lambert Company | Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| NL1015744C2 (nl) * | 2000-07-19 | 2002-01-22 | Dsm Nv | Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten. |
| JP2006512086A (ja) * | 2002-09-20 | 2006-04-13 | ダイヴァーサ コーポレイション | スタチンおよびスタチン中間体の合成のための酵素化学的方法 |
-
2004
- 2004-04-28 AT AT04730128T patent/ATE386734T1/de active
- 2004-04-28 AU AU2004234308A patent/AU2004234308A1/en not_active Abandoned
- 2004-04-28 US US10/554,294 patent/US7423162B2/en not_active Expired - Fee Related
- 2004-04-28 UA UAA200511372A patent/UA83662C2/ru unknown
- 2004-04-28 EA EA200501734A patent/EA010100B1/ru not_active IP Right Cessation
- 2004-04-28 ES ES04730128T patent/ES2300769T3/es not_active Expired - Lifetime
- 2004-04-28 WO PCT/NL2004/000284 patent/WO2004096788A1/en not_active Ceased
- 2004-04-28 NZ NZ543294A patent/NZ543294A/en unknown
- 2004-04-28 DK DK04730128T patent/DK1620423T3/da active
- 2004-04-28 SI SI200430673T patent/SI1620423T1/sl unknown
- 2004-04-28 BR BRPI0409866-8A patent/BRPI0409866A/pt not_active IP Right Cessation
- 2004-04-28 PL PL04730128T patent/PL1620423T3/pl unknown
- 2004-04-28 CN CN201010111364.9A patent/CN101775000B/zh not_active Expired - Fee Related
- 2004-04-28 CA CA002524457A patent/CA2524457A1/en not_active Abandoned
- 2004-04-28 KR KR1020057020818A patent/KR20060011984A/ko not_active Withdrawn
- 2004-04-28 JP JP2006507876A patent/JP2006525323A/ja not_active Withdrawn
- 2004-04-28 CN CN2004800117927A patent/CN1780826B/zh not_active Expired - Fee Related
- 2004-04-28 DE DE602004011921T patent/DE602004011921T2/de not_active Expired - Lifetime
- 2004-04-28 EP EP04730128A patent/EP1620423B1/en not_active Expired - Lifetime
-
2005
- 2005-10-23 IL IL171539A patent/IL171539A/en active IP Right Grant
- 2005-11-01 ZA ZA200508862A patent/ZA200508862B/xx unknown
- 2005-11-02 CO CO05111845A patent/CO5700715A2/es not_active Application Discontinuation
- 2005-11-30 IS IS8159A patent/IS8159A/is unknown
- 2005-12-01 NO NO20055694A patent/NO20055694L/no not_active Application Discontinuation
-
2008
- 2008-05-13 CY CY20081100505T patent/CY1113498T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004234308A1 (en) | 2004-11-11 |
| EP1620423A1 (en) | 2006-02-01 |
| NZ543294A (en) | 2008-05-30 |
| ZA200508862B (en) | 2007-02-28 |
| PL1620423T3 (pl) | 2008-07-31 |
| EA200501734A1 (ru) | 2006-04-28 |
| KR20060011984A (ko) | 2006-02-06 |
| JP2006525323A (ja) | 2006-11-09 |
| ATE386734T1 (de) | 2008-03-15 |
| NO20055694L (no) | 2006-02-02 |
| ES2300769T3 (es) | 2008-06-16 |
| DK1620423T3 (da) | 2008-05-26 |
| EA010100B1 (ru) | 2008-06-30 |
| CO5700715A2 (es) | 2006-11-30 |
| BRPI0409866A (pt) | 2006-05-16 |
| DE602004011921T2 (de) | 2009-02-19 |
| WO2004096788A1 (en) | 2004-11-11 |
| CA2524457A1 (en) | 2004-11-11 |
| EP1620423B1 (en) | 2008-02-20 |
| CN101775000A (zh) | 2010-07-14 |
| CN101775000B (zh) | 2014-09-24 |
| SI1620423T1 (sl) | 2008-06-30 |
| CN1780826A (zh) | 2006-05-31 |
| IL171539A (en) | 2011-03-31 |
| US20060258733A1 (en) | 2006-11-16 |
| CY1113498T1 (el) | 2016-06-22 |
| CN1780826B (zh) | 2010-05-26 |
| US7423162B2 (en) | 2008-09-09 |
| DE602004011921D1 (de) | 2008-04-03 |
| IS8159A (is) | 2005-11-30 |
| UA83662C2 (ru) | 2008-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL377838A1 (pl) | Zastosowanie pochodnych N-(1-benzylo-2-okso-2-(piperazynylo)etylo)-1-piperydynokarboksyamidowych oraz pokrewnych związków jako antagonistów CGRP do leczenia bólu głowy | |
| MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
| CY1106969T1 (el) | Αναστολεις dpp-iv | |
| UA81567C2 (en) | Heteroaroyl-substituted phenylalanine amides | |
| CY1113498T1 (el) | Διαδικασια για την παρασκευη (4-υδροξυ-6-οξο-τετραϋδροπυραν-2-υλ) ακετονιτριλιου και παραγωγων αυτου | |
| CY1108808T1 (el) | Ενωσεις μοτιλιδης | |
| MX2010003849A (es) | Antagonistas de cgrp. | |
| WO2010062038A2 (ko) | 티로신 키나아제 저해 화합물, 이의 이성질체 또는 이의 약학적으로 허용가능한 염 및 이를 포함하는 약학적 조성물 | |
| EA200900797A1 (ru) | Способ синтеза производных 3-аминотетрагидрофуран-3-карбоновой кислоты и их применение в качестве лекарственных средств | |
| NO20081617L (no) | Metoder for fremstilling av Glutaminsyrederivater | |
| SI1751093T1 (sl) | Substituirani derivati cikloheksilocetne kisline | |
| NO20050738L (no) | Ny fremgangsmate for syntesen av (7-metoksy-3,4-dihydro-1-naftalanyl)acetonitril og dens anvendelse i syntesen av agomelatin | |
| SI1745010T1 (sl) | Substituirani cikloheksil-1,4-diaminski derivati | |
| EP1944027A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF NEPHRITIS AND METHOD OF MANUFACTURE THEREOF | |
| NO20054418L (no) | Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse | |
| PT1551827E (pt) | Derivados de piperidina como inibidores de ccr5 | |
| MXPA05010957A (es) | Derivados de ornitina activos farmaceuticamente, sales de amonio de los mismos y metodos para su preparacion. | |
| WO2007006922A3 (fr) | Nouveaux derives 1h-indole-pyridinecarboxamides et 1h-indole-piperidinecarboxamide et leur utilisation comme inducteurs de tyrosine hydroxylase | |
| AU2003272083A1 (en) | Salt of 6-(1, 3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid with n, n-dimethyl-imidodicarbonimidic diamide | |
| TH88753A (th) | สารยับยั้งคิเนส | |
| WO2005014542A3 (de) | Neue n-substituierte indolyl-3-glyoxylsäureamide, deren verwendung als arzneimittel gegen krebs und verfahren zu deren herstellung | |
| TH129873A (th) | อนุพันธ์ฟูโรไพริมิดีนชนิดใหม่, ถูกแทนที่แบบอะไซคลิคและการใช้ของสิ่งเหล่านี้ | |
| TH53587A (th) | สารประกอบทางเคมี | |
| TH67254A (th) | สารยับยั้งไทโรซีนไคเนสชนิดใหม่ | |
| TH71835A (th) | สารประกอบใหม่ 2-พิริดินิลเอธิลเบนแซมีด |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |